Since cytochromes P450 are external monooxygenases, available surrogate redox partners have been used to reconstitute the P450 activity. However, the effect of various ratios of P450s and the redox proteins have not been extensively studied so far, although different combinations of the redox partners have shown variations in substrate conversion. To address this issue, CYP260A1 was reconstituted with various ratios of adrenodoxin and adrenodoxin reductase to convert 11-deoxycorticosterone, and the products were characterized by NMR. We show the effect of the available redox protein ratios not only on the P450 catalytic activity but also on the product pattern.
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Keywords: P450; redox protein-ratios; steroid Cytochromes P450 (P450s), the heme-containing monoxygenase enzymes, are able to catalyze a variety of chemical reactions including C-H functionalization, aromatic hydroxylation, dealkylation, C-C lyase activity, decarboxylation, nitration and carbene transfer [1, 2] . P450s are also involved in the biosynthesis of natural products [3] . They require electrons for their activity, which can be donated by autologous or heterologous redox partners via an electron transfer chain [4] . However, the requirement of efficient redox partners to deliver electrons from NADH or NADPH to a P450 is the bottleneck for its application [5] .
The identification of functional autologous or heterologous redox partners for orphan microbial P450s is complicated, because the P450s and potential redox partners are not always found in the same gene cluster [6] . However, surrogate redox partners are often employed to reconstitute catalytic activities for such novel P450s. Several different redox systems, like putidaredoxin reductase (PdR) -putidaredoxin (Pdx) from Pseudomonas putida, adrenodoxin reductase homolog 1 (Arh) -endogenous ferredoxin component (etp1) from Schizosaccharomyces pombe [7] , ferredoxin reductase (FdR) -ferredoxin (Fdx) from Escherichia coli [8] , ferredoxin reductase (FdR) -flavodoxin (ykuN/ykuP) from Bacillus subtilis [9] , adrenodoxin reductase (AdR) -adrenodoxin (Adx) from bovine adrenals [10] , the reductase domain of CYP102A1 (BMR) [9, 11] , the FMN-and Fe/S-containing domain of p450RhF from Rhodococcus sp. [12] , a phthalate family oxygenase reductase (PFOR) from Pseudomonas putida KT24440 [13] , along with the chimeric systems of SynFdx (Fd) from Synechocystis and the ferredoxin NADP + reductase (FNR) from Chlamydomonas reinhardtii [14] and Adx-FpR from E. coli [15] as well as the commercially available spinach ferredoxin (Fdx) and ferredoxin reductase (FdR) [16, 17] have been used in different ratios to reconstitute the activity of various P450s. However, the ratios of P450 and the redox partners used for the substrate conversions were not consistent in the different studies. In some studies, more than a 10-fold [9, [18] [19] [20] , a 20-fold [21, 22] , a 50-80 fold [23] [24] [25] or even more than a 200-fold [26, 27] higher ratio of Fdx compared with the P450 was employed for the in vitro conversion of the related substrate. In all these studies, the main aim of employing the various ratios was to make the P450 functional, but the effect of different ratios of the redox partners was not studied. Nevertheless, it has been shown that the use of surrogate redox systems for a novel P450 not only showed variations in the substrate conversion [9, 14, 15, 28, 29] but also displayed different product selectivities [30] . In addition, the use of nonphysiological substrates containing multiple oxidation sites to be attacked by a P450, generally resulted in different oxidized products depending on the reaction conditions and incubation time, in which the earlier product(s) might serve as a substrate for further conversions [31, 32] . Such multistep or sequential oxidations of a substrate by a P450 results in either a distributive, (obtaining multihydroxylated products at once as shown, e.g. for CYP19 [33, 34] ) or a processive (step-wise sequential reactions as observed for the conversion of nitrosamines to aldehydes and then carboxylic acids by CYP2A6 [32, 35] ) product distribution.
While using a nonphysiological substrate for a P450 or a mutated variant of a specific P450, in some of the cases, the product patterns that are observed in an in vitro reaction do not replicate in the in vivo conversion [36] . In general, the amounts of the redox partners being present during the coexpression of P450 and redox partners in a whole-cell system are not comparable to the amounts of the redox proteins in the in vitro reaction. Therefore, this study attempted to investigate this issue in more detail. In order to understand the effect of the redox protein ratio of Adx and AdR on the P450-dependent reaction, different amounts of the redox proteins were used for the conversion of 11-deoxycorticosterone (DOC) by CYP260A1. We studied the consequences on the conversion of DOC and its product selectivity during the in vitro reaction and the E. coli-based whole-cell system. The obtained main products were purified and characterized by liquid chromatography-mass spectrometry (LC-MS) and 1D and 2D NMR analysis.
Materials and methods

Molecular cloning, expression and purification of CYP260A1
The heterologous expression, purification and characterization of CYP260A1 were performed as described elsewhere [10] . The mammalian adrenodoxin reductase, AdR, and truncated adrenodoxin, Adx 4-108 , were expressed and purified as described [37, 38] .
In vitro enzyme activity assay
The conversion of DOC by CYP260A1 was carried out with the heterologous electron partners. The in vitro reconstitution assay to determine the steady-state conversion of DOC (100 lM) was performed in a final volume of 250 lL containing a mixture of CYP260A1 (0.5 lM), Adx (5 lM), AdR (1.5 lM) (CYP260A1 : Adx : AdR of 1 : 10 : 3) and substrate (100 lM) in 20 mM potassium phosphate buffer (pH 7.4). The reaction was started by adding NADPH (500 lM) and incubating for 20 min at 30°C, and stopped by the addition of chloroform (500 lL). The sample was mixed vigorously, and the organic phase was extracted twice with chloroform. The pooled samples were dried and analyzed by HPLC as described [10] . The time-dependent conversion was done by increasing the incubation time (5-100 min). The NADPH-dependent conversion of the substrate was done using 100 lM to 4 mM freshly prepared NADPH under the same condition as explained. The reaction was done in the absence or presence of a NADPH regeneration system when needed. The NADPH-regenerating system consists of glucose 6-phosphate (5 mM), glucose 6-phosphate dehydrogenase (1 U) and MgCl 2 (1 mM). Protein ratios of CYP260A1 : Adx : AdR of (1 : 1 : 1, 1 : 2 : 0. Table 1 and Fig. 2 .
To investigate the effect of radical scavengers on the catalytic rate, the in vitro conversions were performed with the addition of ascorbate (20 mM), catalase (20 U) and superoxide-dismutase (SOD) (3 U), individually as well as in combination. To determine whether hydrogen peroxide (H 2 O 2 ) could be applied to reconstitute the activity of CYP260A1, H 2 O 2 was used in a final concentration of 50 lM. The reactions were stopped, extracted and analyzed as described below. All the experiments were performed using the same batch of purified proteins.
Whole-cell biotransformation using resting cells
The whole-cell biotransformation assay was performed in E. coli C43(DE3) cells. The cells were transformed with two plasmids, one for the CYP260A1 and the other one for the redox partners AdR and Adx 4-108 as described [15] . The conversion of DOC by the resting cells expressing the redox partners and CYP260A1 was performed as described [10] .
Detection and analysis of substrate conversion by CYP260A1
The analysis of the DOC conversion in HPLC and LC-MS was performed as described [10] . Briefly, the in vitro and the in vivo conversions of the steroids were analyzed by reversed phase HPLC. After evaporation of the organic (chloroform) phase, the steroids were resuspended in 80% acetonitrile and separated on a Jasco reversed phase HPLC system (Tokyo, Japan) composed of an auto sampler AS-2050 plus, a pump PU-2080, a gradient mixer LG-2080-02 and an UVdetector UV-2075. A reversed phase column (Nucleodur R100-5 C18ec, particle size 3 lm, length 125 mm, internal diameter 4 mm, Macherey-Nagel) was used to separate the substrate (DOC) from its products (1a-,14a-dihydroxy-11-DOC, 1a-hydroxy-11-DOC or C1-C2-ene-11-DOC). The separation of the steroids was done by a gradient elution of acetonitrile 10-100% for 0-10 min and was monitored at 240 nm. The column temperature was kept constant at 40°C with a peltier oven. A quantity of 20 lL of the samples was injected for analysis. The peaks were identified using CHROMPASS software (V.1.7.403.1, Jasco, GrossUmstadt, Germany) and the conversion rate (nmol total product per nmol CYP260A1 per min) was calculated. DOC, 1a-hydroxyl-11-DOC and C1-C2-ene-11-DOC (NMR-characterized) were used as standards to identify the retention time (RT) of the peaks on HPLC.
Binding study of DOC and 1a-hydroxy-11-DOC Spin-state shifts upon substrate binding were assayed at 25°C under aerobic conditions using an UV-visible scanning spectrophotometer (UV-2101PC, Shimadzu, Japan) equipped with two tandem quartz cuvettes (Hellma, M€ ullheim, Germany) as described [10, 29] . One chamber of each cuvette contained 1.12 lM CYP260A1 in 800 lL of 10 mM potassium phosphate buffer, pH 7.4, whereas the second chamber contained buffer alone. The titration of the substrates (DOC and 1a-hydroxyl-11-DOC dissolved in DMSO) was done by adding small (<1 lL) aliquots of an appropriate stock of the substrate into the P450 containing chamber of the sample cuvette. An equal amount of the substrate was also added into the buffer containing chamber of the reference cuvette, and spectral changes between 200 and 700 nm were recorded. The overlaid difference spectra from 350 to 500 nm produced by subtraction of the spectrum for ligandfree CYP260A1 from the successive spectra for substrate-bound species accumulated during the titration of testosterone and androstenedione were obtained.
The dissociation constants (K d ) for CYP260A1 with DOC and 1a-hydroxylated DOC were calculated by fitting the peak-to-trough difference against substrate concentration to a nonlinear tight binding quadratic equation [39] . The relevant equation is: 
NMR characterization of the CYP260A1 product
The fractions of the purified product were pooled and dried in a rotary evaporator. NMR spectra (gs-HH-COSY, gs-NOESY, gs-HSQCED, and gs-HMBC) was recorded using the Bruker pulse program library. 
Results and Discussion
Determination of in vitro steady-state conditions for DOC conversion by CYP260A1
In order to investigate the effect of redox protein ratios for the conversion of DOC by CYP260A1, we employed the bovine redox partners Adx and AdR, which have been identified as the most efficient redox partners for several myxobacterial [15, 29, 40] and Bacillus [9, 41] P450s, as well as the CYP260 family from Sorangium cellulosum So ce56 [10, 42] . Adx is one of the most thoroughly studied redox proteins to date [43] [44] [45] . Furthermore, very recently, we have shown that an E. coli-based whole-cell system with CYP260A1, coexpressing the bovine ferredoxin and an E. coli ferredoxin reductase, was able to convert D4-C19 steroids [10] . However, the effect of the available redox protein pool on the conversion of steroids has not been studied. In this study, we used DOC, the D4 C-21 steroid, as a substrate which is converted into multiple hydroxylated products so that changes in the selectivity can easily be followed. At first, the time dependent in vitro DOC conversion by CYP260A1 at substrate saturation (100 lM) using the ratio of CYP260A1 : Adx : AdR of 1 : 10 : 3 was performed to investigate the steady-state conditions of the conversion (Fig. 1A,B (Fig. 1A) .
We observed that the conversion was in a steadystate condition up to 40 min (Fig. 1B) . In accordance with this, 20 min reaction time was used for the subsequent in vitro conversions utilizing the same batch of the purified CYP260A1, Adx and AdR at a ratio of 1 : 10 : 3 for CYP260A1 : Adx : AdR (0.5 lM : 5 lM : 1.5 lM). In order to determine the concentration of NADPH to be used for the steadystate condition, a saturating concentration of DOC (100 lM) was converted using increasing concentrations of NADPH (Fig. 1C) , which showed values of K m and V max of 354 AE 85 lM and 1.67 AE 0.10 min À1 , respectively. The K m value does not mean the kinetic parameter of AdR, but rather represents the concentration of NADPH at which the reaction rate is half of the maximum rate in the coupling reaction by the redox partners and CYP260A1. Afterwards, for the subsequent study of DOC conversion, 500 lM NADPH was used. Moreover, turnover experiments of DOC (100 lM) in the presence and absence of a NADPH regeneration system were performed, and it was observed that the rate is almost the same as in the case of absence of NADPH recycling (1.7 vs 1.8 min À1 ) (Fig. 1D) . Therefore, for the subsequent conversion of DOC by CYP260A1, different ratios of CYP260A1 and redox partners were used in the absence of NADPH regeneration.
Conversion of DOC by utilizing different ratios of CYP260A1 and redox proteins
In a first set of experiments, we compared the activities of DOC conversion for ratios of P450 : Fdx : FdR, which have been employed in previous studies [46, 47] . At first, an equimolar concentration of P450 : Adx : AdR of 1 : 1 : 1 [46] (Fig. 2, entry A) , and an increased ratio of ferredoxin and decreased ratio of ferredoxin reductase of 1 : 2 : 0.5 [47] (Fig. 2, entry B) , as well as a ratio allowing a higher amount of the reductase compared to the P450 and the ferredoxin of 1 : 1 : 5 ( Fig. 2 , entry C) were used for the in vitro conversion of DOC by CYP260A1. We observed that the conversion consisting of slightly higher molar ratios of Adx compared to CYP260A1 and AdR showed higher turnover (1.23 min
À1
, i.e. nmol total products per nmol CYP260 A1 per min) (Fig. 2, (Fig. 2, entry C) . In addition, we also employed the ratios of 3 : 2.5 : 1 and 8 : 3 : 1 for CYP260A1 : Adx : AdR, displaying a higher molar ratio of P450 compared with the redox partners for DOC conversion. These ratios were used for the in vitro conversion of steroidal substrates by mitochondrial cytochromes P450s using Adx and AdR as redox partners [48] . We observed that the higher ratio of CYP260A1 compared with Adx and AdR did not increase the rate of DOC conversion, showing a turnover of 0.60 min À1 for CYP260A1 :
Adx : AdR of 3 : 2.5 : 1 (Fig. 2, entry D) and of 0.45 min À1 for a ratio of 8 : 3 : 1 (Fig. 2 , entry E).
In order to systematically investigate the effect of the redox protein ratios on DOC conversion, three experimental sets consisting of a 5- (Fig. 2 , entry F-H), 10- (Fig. 2, entry I-N) and 20-fold higher molar ratio of Adx (Fig. 2 , entry O-U) compared with CYP260A1 at increasing ratios of AdR compared with CYP260A1 were used ( Table 1) . We observed a maximum turnover rate of 2.61 AE 0.10 min Adx : AdR of 1 : 20 : 3, 1 : 10 : 3 and 1 : 5 : 3, respectively. Interestingly, it was observed that at higher ratios of AdR than 1:3 compared with CYP260A1 a diminished turnover rate for the substrate conversion was observed, which was also true for the ratio that has been used for an earlier study [48] (Fig. 2, entry C) . In addition, an equal or higher molar ratio of P450 compared to Adx also showed a reduced activity (Fig. 2 , entries A, D-E). In order to reconstitute the activity of several P450s, different ratios of the P450 and redox partners were also employed in earlier studies. However, a higher concentration of ferredoxin with a lower reductase ratio [47, [49] [50] [51] or a higher concentration of P450 compared to Fdx and FdR [52] were used. Very recently, we have observed a higher conversion of epothilone D by the P450 EpoK when using the ratio of 1 : 20 : 3 compared to 1 : 10 : 1 for EpoK : Fdx: reductase (either AdR, Arh1 or FNR).
In general, as shown in Fig. 2 , the highest turnover numbers were obtained with a ratio of CYP260A1 : Adx : AdR of 1 : 20 : 3. It has been shown that a twofold higher concentration of adrenodoxin reductase is required for maximal P450scc (CYP11A1) activity in the presence of a relatively high concentration of adrenodoxin (~10-fold) [53, 54] . During the steady-state conversion of DOC by CYP260A1, we observed that the presence of higher amounts of Adx showed higher activities (Fig. 2) . Although the mechanism of interaction of P450s with Adx-AdR is well studied for CYP11A1 and it has been suggested that Adx can make either productive tertiary or quaternary complexes with bovine CYP11A1 [55, 56] and AdR or can shuttle electrons through the formation of Adx or Adx dimers [57, 58] , the detailed mechanism of the interaction of the redox partners with CYP260A1 still needs to be elucidated. However, it can be suggested that at higher amounts of Adx the delivery of electrons becomes faster thus leading to an efficient DOC conversion. In contrast, the increase in the AdR concentration compared to CYP260A1 and Adx in the in vitro reaction significantly dropped the rate of DOC conversion (Fig. 2) , which might be the result of a decreased concentration of free Adx protein that is required for shuttling the electrons from the AdR to CYP260A1. In addition, the higher rate of nonspecific NADPH oxidation by the increased reductase concentration could also account for the lower conversion. 
Effect of redox protein ratios on the product pattern of the DOC conversion by CYP260A1
Most interestingly, the in vitro product pattern of DOC conversion using different ratios of P450 and the redox proteins changed significantly when using various ratios of the proteins. Although the same six product peaks were observed as under the steady-state conditions (Fig. 1B) , their relationship changed considerably, especially for the major product peaks 4 (t R = 5.28 min, Dm/z of +16) and 6 (t R = 7.13 min, Dm/z of +2) as well as the minor product peak 1 (t R = 4.13 min, Dm/z of +32) (Figs 3A and S1 ). When the ratio of CYP260A1 : Adx : AdR was 1 : 5 : 3, peak 6 was the highest followed by peak 4 (Fig. 3A) . In order to study the effect of the incubation time of the reaction, time-dependent DOC conversion in the presence and absence of a NADPH recycling system was performed. However, there was no change in the product pattern (Fig. S1) .
When increasing the amount of the redox proteins relative to CYP260A1 to a ratio of CYP260A1 : Adx : AdR of 1 : 10 : 3 or 1 : 20 : 3, product peak 6 was gradually decreased and peak 4 (t R = 5.28 min) was increased (Fig. 3A) , respectively. The time-dependent product formation observed by using CYP : Adx : AdR of 1 : 10 : 3 in the absence of a NADPH recycling system did not show any differences in the product pattern compared with the 30 min to 2 h reaction time (Fig. S2) .
In a subsequent experiment, when the time-dependent conversion of DOC was performed in the presence of a NADPH recycling system and the highest ratio of the redox proteins (CYP260A1 : Adx : AdR of 1 : 20 : 3), the highest yield of the product peak 1 (t R = 4.13 min) was obtained followed by the product peaks 4 and 6 during a longer reaction time (1 h to 2 h) (Figs 4 and S3) . However, analysis of the products obtained until 30 min showed the highest formation of peak 4 followed by peaks 1 and 6 (Fig. S3) .
In addition, since surrogated redox proteins generally cause low coupling efficiency during the consumption of either substrates or cofactors and thus can generate reactive oxygen species (ROS), the in vitro conversions were performed with the addition of radical scavengers for the ratio of 1 : 10 : 3 of CYP260A1 : Adx : AdR. As scavenging agents ascorbate (neutralizing the superoxide radical, singlet oxygen and hydroxyl radicals), catalase (decomposing hydrogen peroxide to water and oxygen) and superoxide dismutase (SOD) (scavenger of superoxide anion) were employed either individually or in combination. There was no significant decrease in the catalytic rate compared with the control (Fig. 5, Table S3 ). In addition, to exclude the role of possible H 2 O 2 -mediated substrate conversion in the P450 catalysis [34, 41, 59] , the in vitro conversion of DOC was also performed in the presence of hydrogen peroxide. However, using H 2 O 2 only a negligible amount of product was formed.
An Escherichia coli-based whole-cell bioconversion of DOC and characterization of the products Since we were interested to characterize the product peaks 1, 4 and 6, which were changed according to the availability of the redox proteins in the in vitro Table S1 . reaction, CYP260A1 dependent E. coli-based wholecell bioconversion of DOC was performed. The in vivo conversion of DOC using CYP260A1 and a coexpression of Adx and AdR showed an identical product pattern as during the in vitro reaction (Figs 3 and 6) . Interestingly, the conversion of DOC after 24 h using resting E. coli cells that have been coexpressed with the three proteins for 24 h showed the highest yield of peak 6 (t R = 7.13 min, Dm/z of +2) followed by peak 4 (t R = 5.28 min, Dm/z of +16) and peak 1 (t R = 7.13 min, Dm/z of +32) (Fig. 6A) . In contrast, a longer conversion period (48 h) showed a diminished yield of peak 6 and a subsequent increase in peaks 4 and 1 (Fig. 6B) . However, resting cells that were coexpressed with the three proteins for a longer duration (48 h) showed the highest yield of peak 4 followed by peaks 6 and 1 for both the conversion conditions (24 h and 48 h) (Fig. 6C,D) . It is interesting that the product peak 1, the yield of which was almost negligible during in vitro conversion under steady conditions (performed in the absence of NADPH recycling), has appeared as a major product either during the in vitro conversion for a longer time in the presence of NADPH recycling or in the in vivo conversion of DOC. Therefore, the appearance of peak 1 seems to be closely related to the availability of sufficient amounts of recycled NADPH and redox proteins.
Our optimized E. coli-based whole-cell system for the conversion of DOC by CYP260A1 was able to give enough yield to purify the corresponding products. The products comprising the peaks 1, 4 and 6 were purified and characterized by LC-MS and 1D and 2D NMR. Products 1 (Dm/z of +32), 4 (Dm/z of +16) and 6 (Dm/z of À2) were identified as 1a-,14a-dihydroxy-11-DOC (1a-,14a-dihydroxylated DOC), 1a-hydroxy-11-DOC (1a-hydroxylated DOC) and 11-deoxycorticosterone-1-ene (21-hydroxypregna-1,4-diene-3, 20-dione or C1-C2-ene-11-DOC), respectively. Product 1 is a novel steroid derivative and the major product 4 is the same one as was identified before as the main product of CYP260A1-dependent DOC conversion [60] . Although CYP260A1 performs mainly the C-1 hydroxylation of DOC, the position at C-2 is prone for hydrogen abstraction and can act as a proton donor. This might result in a chemical modification at C-1 to generate a product with a C-1/C-2 double bond, because of the possible delocalization of the p system after releasing a water molecule from the A-ring. This hypothesis is supported by the existence of the product peak 6 (C1-C2-ene-11-DOC) along with the major peak 4. The NMR data of product 6 also corroborated with the published 13 C NMR data [61] . The detailed results of NMR spectroscopy or the products 1, 4 and 6 are as follows.
1a-,14a-Dihydroxy-11-deoxycorticosterone (1a-,14a-dihydroxylated DOC) (Product 1): The reaction mixture consists of CYP260A1 : Adx : AdR of 1 : 20 : 3 in the presence of a NADPH recycling system. The conversion was done for 1 h. The products corresponding to peaks 1, 4 and 6 were identified as 1a-, 14 adihydroxy-11-DOC, 1a-hydroxy-11-DOC, and C1-C2-ene-11-DOC, respectively. The peak 'S' represents the substrate DOC. (B) The relative percentage of the product peaks 1 (black bar), 4 (gray bar) and 6 (empty bar) of DOC conversion are shown. The number on the bar represents the value of the relative selectivity (in %) for the products. The error bar represents the standard deviation of 3-5 independent measurements, and the values are shown in the Table S2 . In order to study, whether the product peaks 1 (1a-,14a-dihydroxy-11-DOC) and 6 (C1-C2-ene-11-DOC) were derived from the major product peak 4 (1a-hydroxy-11-DOC), we investigated the conversion of purified 1a-hydroxy-11-DOC either in the presence or in the absence of a NADPH recycling system with a protein ratio of 1 : 10 : 3 for CYP260A1 : Adx : AdR. We observed the formation of product peaks 1 and 6 during the conversion of 1a-hydroxy-11-DOC, thus supporting a processive reaction type. Interestingly, the presence of a NADPH recycling system showed a higher amount of product peak 1 followed by peak 6 compared with the conversion done for 30 min in the absence of the recycling system (Fig. 7) , suggesting that the availability of higher amounts of redox proteins in vitro promoted the further conversion of the primary product(s) into subsequent secondary product(s). Although we showed further conversion of peak 6 (C1-C2-ene-11-DOC) into peak 4 (1a-hydroxy-11-DOC) under in vivo conditions (Fig. 6 ) or upon complete consumption of DOC in the in vitro reaction (Figs 4 and S3) , it seemed controversial that peak 6 was also observed during the conversion of peak 4 (1a-hydroxy-11-DOC) as a substrate (Fig. 7) . However, because of the possible delocalization of the p-system during the release of a water molecule from the A-ring of 1a-hydroxy-11-DOC, the C-1 could readily generate isomers with a C-1 and C-2 double bond to give peak 6 (C1-C2-ene-11-DOC). The mechanism for the predominance of peak 4 either by a spontaneous conversion of C1-C2-ene-11-DOC or CYP260A1 mediated hydration reaction is not elucidated.
Since we observed the further conversion of 1a-hydroxy-11-DOC to 1a-,14a-dihydroxy-11-DOC and C1-C2-ene-11-DOC by CYP260A1, we were interested to study the binding affinity of DOC and its major conversion product 1a-hydroxy-11-DOC for CYP2 60A1. Interestingly, 1a-hydroxy-11-DOC showed an about~2-fold tighter binding compared with DOC displaying K d values of 0.52 AE 0.14 lM and 0.27 AE 0.01 lM for DOC and 1a-hydroxy-11-DOC, respectively (Fig. 8) . This observation suggests that the binding of the surrogate redox partners might have induced an open confirmation of CYP260A1 so that 1a-hydroxy-11-DOC can be released from CYP260A1 and enter again into the active site of CYP260A1 in a different orientation. Indeed, our very recent study on the docking of DOC into the crystal structure of CYP260A1 also showed two different orientations of DOC in its active site [59] , in which DOC was oriented either having ring-A or ring-D close to the heme center (Fig. S4) . We hypothesized that the major product 1a-hydroxy-11-DOC might have re-entered into the active site of CYP260A1 in a flipped orientation compared with the position allowing the most feasible 1a-hydroxylation to reveal an additional hydroxylation site at position 14 producing 1a-,14a-dihydroxy-11-DOC. Most importantly, the observed open conformation of P450cam complexed with its redox partner putidaredoxin (Pdx) in the crystal structure of oxidized and reduced form [62] also suggested that the redox protein induced an open conformation.
In conclusion, the conversion of DOC by CYP260A1 showed three main product peaks (1, 4 and 6) and the product patterns varied in Fig. 7 . Conversion of 1a-hydroxy-11-DOC by CYP260A1. Chromatograms of DOC (A) and the purified 1a-hydroxy-11-DOC (B); the chromatogram showing the conversion of 1a-hydroxy-11-DOC, peak 4, (B) into the product peaks 1 and 6 in the absence (C) and presence (D) of a NADPH recycling system. The activity was reconstituted with the heterologous redox partners Adx and AdR. The ratio of CYP260A1 : Adx : AdR was 1 : 10 : 3. The reactions in the absence (C) and presence (D) of a NADPH recycling system were done for 30 min and 1 h, respectively. The products corresponding to peaks 1, 4 and 6 were identified as 1a-, 14a-dihydroxylated-11-DOC, 1a-hydroxy-11-DOC, and 11-deoxycorticost erone-1-ene (C1-C2-ene-11-DOC), respectively. The asterisk '*' represent the unidentified product.
dependence on the employed redox protein ratios. A low concentration of the redox proteins (CYP260A1 : Adx : AdR of 1 : 5 : 3) showed the formation of peak 6 (C1-C2-ene-11-DOC) as the major one followed by peak 4 (P6 > P4). When using higher redox protein ratios (1 : 10 : 3 and 1 : 20 : 3 for CYP260A1 : Adx : AdR), the in vitro conversion showed the formation of peak 4 (1a-hydroxy-11-DOC) as the major one. However, the product peak 6 was higher for the ratio 1 : 10 : 3 compared with 1 : 20 : 3 showing product patterns of P4 > P6 > P1 and P4 > P1 > P6, respectively (Fig. 3) . In addition, the presence of higher amounts of redox proteins (CYP260A1 : Adx : AdR of 1 : 20 : 3) and the availability of a cofactor (NADPH) recycling system showed the highest yield of the product peak 1 (1a-, The inset B shows the overlaid difference spectra produced by subtraction of the spectrum for ligand-free CYP260A1 from the successive spectra for substratebound species accumulated during the titration between 0 and 2 lM of DOC (Panel I) and 0 and 2.5 lM of 1a-hydroxy-11-DOC (Panel II). The plots of absorbance change vs. concentration of the substrate from the titration were plotted to a tight binding quadratic equation as described in 'Materials and Methods' and the CYP260A1 dissociation constants (K d value) were identified (inset C).
14a-dihydroxy-11-DOC) followed by the peaks 4 and peak 6 (Fig. 4) . We also showed the conversion of the purified product of peak 4 into peaks 1 and 6, suggesting further conversion of the preformed product(s). Taken together, this study showed that the amount of redox partners can be used to tune the P450-dependent reaction either producing one main product (1a-hydroxy-11-DOC) or getting a more diverse product spectrum (e.g. 1a-, 14a-dihydroxy-11-DOC or C1-C2-ene-11-DOC) as illustrated in Scheme 1.
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